Neuphoria Therapeutics (NEUP) Earnings Analysis
Neuphoria Therapeutics (NEUP) next reports earnings on 2026-09-02, consensus EPS -0.56 USD. Last quarter (2026-05-15) it beat with EPS -0.09 USD vs -0.56 USD est (+83.9%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -0.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NEUP next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.56 USD |
| Revenue estimate | n/a |
NEUP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.09 USD | -0.56 USD | +83.9% | Beat |
| 2026-02-17 | -0.77 USD | -0.56 USD | -37.5% | Miss |
| 2025-11-14 | -4.41 USD | -0.55 USD | -701.8% | Miss |
| 2025-09-29 | -5.79 USD | -0.56 USD | -933.9% | Miss |
| 2025-05-20 | 6.55 USD | -0.47 USD | +1493.6% | Beat |
| 2025-03-17 | -0.0083 USD | -2.01 USD | +99.6% | Beat |
| 2024-11-14 | -0.00344 USD | n/a | n/a | n/a |
| 2024-09-30 | -29.15568 USD | -11.3796 USD | -156.2% | Miss |
Beat rate: 3/7 (43%) over reported quarters with consensus data.
NEUP valuation and analyst view
| Trailing P/E | -0.30 |
|---|---|
| Trailing EPS | -5.26356 USD |
| Price / book | 0.61 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (1 buy / 1 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is Neuphoria Therapeutics (NEUP)'s next earnings date?
Neuphoria Therapeutics is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.56 USD.
Did NEUP beat earnings last quarter?
In its 2026-05-15 report, NEUP posted EPS of -0.09 USD versus a -0.56 USD estimate — a beat of 83.9%.
What is NEUP's earnings track record?
Over the last 7 reported quarters with consensus data, NEUP beat estimates 3 times (43%).
What is NEUP's current P/E ratio and EPS?
NEUP trades at a trailing P/E of -0.30 on trailing EPS of -5.263561946199432 USD.
What do analysts rate NEUP?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.